AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INVION LTD

0.110

-0.005-4.35%

Volume:51.27K

Turnover:5.44K

Market Cap:9.34M

PE:-1.04

High:0.110

Open:0.110

Low:0.105

Close:0.115

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVION LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

4

Office Location:

100 Albert Road,Level 4,Melbourne,Victoria,Australia

Website:

http://www.inviongroup.com

Zip Code:

3205

Phone:

Fax:

- -

Introduction:

Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.11,"timestamp":1752819120000,"preClose":0.115,"halted":0,"volume":51266,"delay":0,"nameEN":"INVION LTD","floatShares":56201428,"shares":84875801,"eps":-0.105328,"marketStatus":"Market Closed","change":-0.005,"latestTime":"07-18 16:12:00 AEST","open":0.11,"high":0.11,"low":0.105,"amount":5435,"amplitude":0.043478,"askPrice":0.11,"askSize":32443,"bidPrice":0.105,"bidSize":7022,"shortable":3,"etf":0,"ttmEps":-0.105328,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.115,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":0.5715693693024049,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":56201428,"roa":"-26.39%","roe":"-43.80%","lyrEps":-0.087599,"volumeRatio":0.5715693693024049,"shares":84875801,"dividePrice":0,"high":0.11,"amplitude":0.043478,"preClose":0.115,"low":0.105,"week52Low":0.078,"pbRate":"0.71","psRate":"6.37","week52High":0.43,"institutionHeld":0,"latestPrice":0.11,"committee":-0.64414,"eps":-0.105328,"divideRate":0,"volume":51266,"delay":0,"ttmEps":-0.105328,"open":0.11,"prevYearClose":0.28,"prevWeekClose":0.105,"prevMonthClose":0.11,"prevQuarterClose":0.11,"fiveDayClose":0.105,"twentyDayClose":0.125,"sixtyDayClose":0.1},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28625535,"yearFounded":2000,"employeeNum":4,"address":"100 Albert Road,Level 4,Melbourne,Victoria,Australia","zipCode":"3205","officePhone":"61 3 9692 7222"},"stockCompanyDetail":{"websiteUrl":"http://www.inviongroup.com","stockEarnings":[{"period":"1week","weight":0.0476},{"period":"1month","weight":-0.1852},{"period":"3month","weight":0.1224},{"period":"6month","weight":-0.5417},{"period":"1year","weight":-0.725},{"period":"ytd","weight":-0.6071}],"compareEarnings":[{"period":"1week","weight":0.0051},{"period":"1month","weight":0.0141},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.1393},{"period":"1year","weight":0.2056},{"period":"ytd","weight":0.1562}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.035796},{"month":2,"riseRate":0.4375,"avgChangeRate":0.115888},{"month":3,"riseRate":0.25,"avgChangeRate":0.010159},{"month":4,"riseRate":0.1875,"avgChangeRate":-0.028761},{"month":5,"riseRate":0.25,"avgChangeRate":-0.088804},{"month":6,"riseRate":0.5625,"avgChangeRate":0.129474},{"month":7,"riseRate":0.2,"avgChangeRate":-0.065701},{"month":8,"riseRate":0.266667,"avgChangeRate":0.064653},{"month":9,"riseRate":0.333333,"avgChangeRate":0.012276},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.034855},{"month":11,"riseRate":0.266667,"avgChangeRate":-0.067962},{"month":12,"riseRate":0.4,"avgChangeRate":0.128117}],"exchange":"ASX","name":"INVION LTD","nameEN":"INVION LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[]}}